Johanna Friedl-naderer
Chief Commercial Officer at Dyne Therapeutics, Inc. (DYN)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 8SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 900153,082 held (−1%) | $24.35 | $22K | -31.7% |
| Sep 8SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 185152,897 held (−0%) | $18.88 | $3K | -11.9% |
| Aug 17SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 226153,982 held (−0%) | $26.28 | $6K | -36.7% |
| Jun 17SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 145154,208 held (−0%) | $18.33 | $3K | -9.2% |
| May 14SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 228154,353 held (−0%) | $18.36 | $4K | -9.4% |
| Mar 6SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 148154,581 held (−0%) | $14.90 | $2K | +11.7% |
| Dec 5SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 14494,729 held (−0%) | $20.72 | $3K | -19.7% |
- Sell
Chief Commercial Officer Johanna Friedl-naderer sold $22K of DYN at $24.35 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Commercial Officer Johanna Friedl-naderer sold $3K of DYN at $18.88 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Commercial Officer Johanna Friedl-naderer sold $6K of DYN at $26.28 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Commercial Officer Johanna Friedl-naderer sold $3K of DYN at $18.33 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Commercial Officer Johanna Friedl-naderer sold $4K of DYN at $18.36 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Commercial Officer Johanna Friedl-naderer sold $2K of DYN at $14.90 — pre-scheduled 10b5-1 plan sale.